Private Portfolio Partners LLC Bristol Myers Squibb CO Transaction History

Private Portfolio Partners LLC

$122 Million
Q2 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $93,465 - $105,971	-1,948 Reduced 6.86%	26,441 $1.43 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $120,230 - $143,468	-2,480 Reduced 8.03%	28,389 $1.46 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $315,153 - $352,390	-5,444 Reduced 14.99%	30,869 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $161,632 - $179,467	-2,537 Reduced 6.53%	36,313 $2.32 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $8,936 - $10,136	136 Added 0.35%	38,850 $2.69 Million
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $5,341 - $6,325	78 Added 0.2%	38,714 $2.79 Million
Q3 2022 Mar 14, 2023	SELL	$0.13 - $76.84 $31 - $18,518	-241 Reduced 0.62%	38,636 $2.75 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $31 - $18,518	-241 Reduced 0.62%	38,636 $2.75 Million
Q2 2022 Mar 14, 2023	SELL	$72.62 - $79.98 $14,524 - $15,996	-200 Reduced 0.51%	38,877 $2.99 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $14,596 - $16,075	-201 Reduced 0.51%	38,877 $2.99 Million
Q1 2022 Mar 14, 2023	BUY	$61.48 - $73.72 $43,404 - $52,046	706 Added 1.84%	39,077 $2.85 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $43,466 - $52,120	707 Added 1.84%	39,078 $2.85 Million
Q4 2021 Mar 14, 2023	BUY	$53.63 - $62.52 $67,788 - $79,025	1,264 Added 3.41%	38,371 $2.39 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $67,734 - $78,962	1,263 Added 3.4%	38,371 $2.39 Million
Q3 2021 Mar 14, 2023	SELL	$59.17 - $69.31 $47,336 - $55,448	-800 Reduced 2.11%	37,107 $2.2 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $47,276 - $55,378	-799 Reduced 2.11%	37,108 $2.2 Million
Q2 2021 Mar 14, 2023	SELL	$61.91 - $67.42 $91,317 - $99,444	-1,475 Reduced 3.75%	37,907 $2.53 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $91,379 - $99,511	-1,476 Reduced 3.75%	37,907 $2.53 Million
Q1 2021 Mar 14, 2023	BUY	$59.34 - $66.74 $1,246 - $1,401	21 Added 0.05%	39,382 $2.49 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1,246 - $1,401	21 Added 0.05%	39,383 $2.49 Million
Q4 2020 Mar 14, 2023	BUY	$57.74 - $65.43 $18,476 - $20,937	320 Added 0.82%	39,361 $2.44 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $18,534 - $21,003	321 Added 0.82%	39,362 $2.44 Million
Q3 2020 Mar 14, 2023	BUY	$57.43 - $63.64 $18,779 - $20,810	327 Added 0.84%	39,041 $2.35 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $52,031 - $57,657	906 Added 2.38%	39,041 $2.35 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $14,801 - $17,304	270 Added 0.71%	38,135 $2.24 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $50,112 - $72,824	1,080 Added 2.94%	37,865 $2.11 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $193,444 - $252,330	3,931 Added 11.97%	36,785 $2.36 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $9,708 - $11,511	-227 Reduced 0.69%	32,854 $1.67 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $292,216 - $323,127	6,549 Added 24.68%	33,081 $1.5 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $35,870 - $42,771	-795 Reduced 2.91%	26,532 $1.27 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $1.33 Million - $1.73 Million	27,327 New	27,327 $1.42 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.

Account